AzTrials
AzTrials

StrokeNCT02817867

Association Between Brain Stimulations for the Rehabilitation of Chronic Stroke Patients

A study testing tDCS, TMS and tDCS + TMS in people with Stroke, run by Federal University of Health Science of Porto Alegre at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Cerebrovascular accident (CVA) is a cerebrovascular disease with high incidence and morbidity in the Brazilian population, and is considered a major cause of disability in adults. Read more about this study

Who is it for?
Ages 18 to 85 years
Conditions the study is for
Stroke
What is being tested?
tDCS, TMS and tDCS + TMS
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
45 participants
Where
1 siteBrazil
Study dates
Jun 2016to Dec 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Subcortical stroke diagnosis, which has resulted in hemiparesis for at least 6 months and not more than 5 years (chronic condition);
  • Ability to reach 60 degrees in the shoulder flexion
  • Ability to completely extend the fingers in the affected upper limb;
  • Minimal cognitive ability to understand commands;
  • No current use of antiepileptic drugs for seizures.

Who cannot join

  • Painful shoulder, adhesive capsulitis or glenohumeral subluxation;
  • Contraindication (presence of metallic implants) or risks for the Transcranial magnetic stimulation, as evaluated by means of a standard questionnaire;

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Federal University of Health Sciences of Porto Alegre

    Porto Alegre, Rio Grande do Sul

Other trials in Brazil

About this study

Official title: Association Between Transcranial Magnetic Stimulation and Transcranial Direct Current Stimulation for Chronic Stroke Patients Rehabilitation: a Randomized Clinical Trial.

Cerebrovascular accident (CVA) is a cerebrovascular disease with high incidence and morbidity in the Brazilian population, and is considered a major cause of disability in adults. Brain damage caused by stroke generates a maladaptive pattern of neural activity and modulation between the cerebral hemispheres, unbalancing in the inter-hemispheric inhibition. This condition affects patient's functional recovery.

The aim of this study is to verify the effectiveness of repetitive transcranial magnetic stimulation Association (rTMS) in the cortex motor contralesional, Transcranial Direct Current Stimulation (tDCS) in the motor cortex ipsilesional and the association between these two types of brain stimulations on the upper limb recovery after stroke.

Conditions
Stroke
Being tested
tDCS, TMS, tDCS + TMS
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • tDCSDevice

    Transcranial direct current stimulation (tDCS)

  • TMSDevice

    Transcranial magnetic stimulation

  • tDCS + TMSDevice

    Association between tDCS and TMS.

Study groups in NCT02817867
Study groupRoleWhat they receive
tDCSActive comparatorPatients who will be treated with Transcranial direct-current stimulation (tDCS) in the ipsilesional motor cortex.
Receives: Device: tDCS
rTMSActive comparatorPatients who will be treated with Magnetic brain stimulation (rTMS) in the contralesional motor cortex.
Receives: Device: TMS
tDCS + rTMSExperimentalPatients who will be treated with the association between Transcranial direct-current stimulation (tDCS) and magnetic brain stimulation (rTMS), in the ipsilesional and contralesional motor cortex, respectively.
Receives: Device: tDCS + TMS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Motor Function by means of the Wolf Motor Function Test

    Measured: change from pre to post (at least 10 days)

Secondary outcomes (3)
  1. Grip strength via hand dynamometer

    Measured: change from pre to post (at least 10 days)

  2. Manual Dexterity by means of the Box and Block Test

    Measured: change from pre to post (at least 10 days)

  3. Quality of Life by means of the Stroke Impact Scale

    Measured: change from pre to post (at least 10 days)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jun 2016 (estimated)
  2. Study startJun 2016
  3. Primary completionOct 2017
  4. Study completionDec 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
45 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02817867
Sponsor's protocol ID
APPG-2016
Status last verified
Jun 2019
First submitted
27 Jun 2016
Last updated
13 Jun 2019
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing tDCS, TMS and tDCS + TMS in people with Stroke, run by Federal University of Health Science of Porto Alegre at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Jun 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Motor Function by means of the Wolf Motor Function Test (time frame: change from pre to post (at least 10 days)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jun 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in